The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results from a phase 2 study on dalpiciclib and pyrotinib, a dual-oral chemotherapy-free regimen in HER2-positive advanced breast cancer (DAP-HER-01).
 
Min Yan
No Relationships to Disclose
 
Limin Niu
No Relationships to Disclose
 
Huimin Lv
No Relationships to Disclose
 
Mengwei Zhang
No Relationships to Disclose
 
Zhenzhen Liu
No Relationships to Disclose
 
Xiuchun Chen
No Relationships to Disclose
 
Zhenduo Lu
No Relationships to Disclose
 
Chongjian Zhang
No Relationships to Disclose
 
Huiai Zeng
No Relationships to Disclose
 
Shengnan Zhao
No Relationships to Disclose
 
Yajing Feng
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Huihui Sun
No Relationships to Disclose
 
Huajun Li
Employment - Jiangsu Hengrui Pharmaceuticals